Silencing the Girdin gene enhances radio-sensitivity of hepatocellular carcinoma via suppression of glycolytic metabolism

BACKGROUND: Radiotherapy has been used increasingly to treat primary hepatocellular carcinoma. Clinically, the main cause of radiotherapy failure is cellular radioresistance, conferred via glycolytic metabolism. Our previous study demonstrated that Girdin is upregulated in primary hepatocellular car...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Li, Sun, Yifan, Li, Jingjing, Wang, Yan, Zhu, Yuxing, Shi, Yong, Fan, Xiaojun, Zhou, Jianda, Bao, Ying, Xiao, Jie, Cao, Ke, Cao, Peiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558715/
https://www.ncbi.nlm.nih.gov/pubmed/28810896
http://dx.doi.org/10.1186/s13046-017-0580-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558715/
https://www.ncbi.nlm.nih.gov/pubmed/28810896
http://dx.doi.org/10.1186/s13046-017-0580-7

Ejemplares similares